Joni K. Evans

Joni K. Evans

Auto-generated profile, based on publicly available information

Joni K. Evans

Division of Public Health Sciences, Department of Biostatistics and Data Science, Wake Forest University School of Medicine, Winston-Salem, NC, USA

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 September 2023 in Journal of the American Heart Association
Verified
Journal Article
Open access
RKRichard Kazibwe
Richard Kazibwe
PCParag A. Chevli
Parag A. Chevli
JEJoni K. Evans
Joni K. Evans
MAMatthew Allison
Matthew Allison
EMErin D. Michos
Erin D. Michos
MMMorgana Mongraw‐Chaffin
Morgana Mongraw‐Chaffin
Background: The relationship between alcohol consumption and ectopic fat distribution, both known factors for cardiovascular disease, remains understudied. Therefore, we aimed to examine the association between alcohol consumption and ectopic adiposity in adults at risk for cardiovascular disease. Methods and Results: In this cross‐sectional analysis, we categorized alcohol intake among participants in MESA (Multi‐Ethnic Study of Atherosclerosis) as follows (drinks/day): 2 (heavy drinking), former drinking, and lifetime abstention. Binge drinking was defined as consuming ≥5 drinks on 1 occasion in the past month. Visceral, subcutaneous, and intermuscular fat area, pericardial fat volume, and hepatic fat attenuation were measured using noncontrast computed tomography. Using multivariable linear regression, we examined the associations between categories of alcohol consumption and natural log‐transformed fat in ectopic depots. We included 6756 MESA participants (62.1±10.2 years; 47.2% women), of whom 6734 and 1934 had chest computed tomography (pericardial and hepatic fat) and abdominal computed tomography (subcutaneous, intermuscular, and visceral fat), respectively. In adjusted analysis, heavy drinking, relative to lifetime abstention, was associated with a higher (relative percent difference) pericardial 15.1 [95% CI, 7.1–27.7], hepatic 3.4 [95% CI, 0.1–6.8], visceral 2.5 [95% CI, −10.4 to 17.2], and intermuscular 5.2 [95% CI, −6.6 to 18.4] fat but lower subcutaneous fat −3.5 [95% CI, −15.5 to 10.2]). The associations between alcohol consumption and ectopic adiposity exhibited a J‐shaped pattern. Binge drinking, relative to light‐to‐moderate drinking, was also associated with higher ectopic fat. Conclusions: Alcohol consumption had a J‐shaped association with ectopic adiposity. Both heavy alcohol intake and binge alcohol drinking were associated with higher ectopic fat.

11 January 2023 in The Journal of Foot and Ankle Surgery
Verified
Journal Article
Closed access
BRBrennan K. Reardon
Brennan K. Reardon
LLLuke E. Leffler
Luke E. Leffler
HHHayden L. Hoffler
Hayden L. Hoffler
JEJoni K. Evans
Joni K. Evans
CBCody D. Blazek
Cody D. Blazek
DDDekarlos M. Dial
Dekarlos M. Dial

6 April 2024 in The Journal of Foot and Ankle Surgery
Verified
Journal Article
Closed access
JKJennifer Kipp
Jennifer Kipp
LLLindsay K. LeSavage
Lindsay K. LeSavage
JEJoni K. Evans
Joni K. Evans
TDTravis A. Denmeade
Travis A. Denmeade
CBCody D. Blazek
Cody D. Blazek

27 May 2025 in Future Oncology
Verified
Journal Article
Closed access
Alyssa GuoAlyssa Guo
Alyssa Guo
MKMary-Peyton Knapp
Mary-Peyton Knapp
JEJoni K. Evans
Joni K. Evans
AFAndrew Faucheux
Andrew Faucheux
SPSarah N. Price
Sarah N. Price
TLThomas W. Lycan
Thomas W. Lycan
Nearly half of patients with cancer are diagnosed at 70 years or older, which presents challenges in cancer care due to their high comorbidity burden and the underrepresentation of this age group in clinical trials. This retrospective study evaluated the association between comorbidity burden and immune checkpoint inhibitors (ICIs) treatment outcomes among older adults. Data were collected from patients aged 70 years or older at the time of diagnosis who were treated with ICIs from 2011 to 2022. Key clinical outcomes include changes in performance status, overall survival (OS), progression-free survival (PFS), and immune-related adverse events (irAEs) and were compared between low baseline Charlson Comorbidity Index (CCI) and high CCI (<4 vs. ≥4) groups. Among 1,223 patients, patients with CCI scores ≥4 (n = 300) had a significantly shorter OS (11.4 vs. 13.6 months, p = 0.0461) but similar PFS (8.0 vs. 7.7 months, p = 0.258) compared to patients with CCI scores <4. There was no significant difference in changes in performance status pre- and post-treatment (p = 0.14) or in the irAE prevalence between the two groups (39.3% vs. 38.3%, p = 0.786). Our study suggests that ICIs are safe in patients with high comorbidity burden but that the presence of pre-treatment comorbidities decreases overall survival.

3 July 2023 in Clinical Toxicology
Verified
Journal Article
Closed access
MAMichael S. Argenyi
Michael S. Argenyi
JEJoni K. Evans
Joni K. Evans
YGYasmin Gay
Yasmin Gay
DEDavid H. Epstein
David H. Epstein
SWStephanie T. Weiss
Stephanie T. Weiss
IntroductionCommunity programs to teach nonmedical laypeople how to recognize an opioid overdose and effectively resuscitate the victim using naloxone have proliferated recently as a significant component of harm-reduction efforts. Although many such programs target laypeople like first responders or friends and family members of people who use drugs, there are currently no programs that specifically target addiction counselors, despite their work with a client population at high risk of an opioid overdose.MethodsThe four-hour curriculum designed by the authors covered opioid agonist and antagonist pharmacology; opioid toxidrome signs; legal implications and indications for using the naloxone kits; and hands-on training. Participants were two cohorts of addiction counselors and addiction counseling trainees at our institution and an affiliated Opioid Treatment Program methadone clinic. Surveys testing participant knowledge and confidence were conducted at baseline, immediately post-training, six months post-training, and 12 months post-training.ResultsOverall, opioid and naloxone pharmacology knowledge, as well as the confidence to intervene in an overdose emergency, improved among participants in both cohorts. Knowledge scores at baseline (n = 36, median 5/10) improved significantly immediately post-training (n = 31, median 7/10, P < 0.0001, Wilcoxon signed-rank test) and were sustained six (n = 19) and 12 months (n = 11) later. Two participants reported using their naloxone kits to successfully reverse a client overdose in the 12 months after taking the course.DiscussionThese results from our knowledge translation pilot project suggest that our educational program to train addiction counselors in opioid pharmacology and toxicology, allowing them to recognize and respond to an opioid overdose, is feasible and could be effective. Specific barriers to implementing such educational programs include cost, stigma, and unclear best practice for designing and conducting these programs.ConclusionsFurther study of providing opioid pharmacology education and overdose and naloxone training to addiction counselors and counseling trainees appears to be warranted.

8 September 2025 in Foot & Ankle International
Verified
Journal Article
Closed access
JKJennifer Kipp
Jennifer Kipp
LLLindsay K. LeSavage
Lindsay K. LeSavage
JEJoni K. Evans
Joni K. Evans
JTJulia C. Tolin
Julia C. Tolin
JVJulianne Vesce
Julianne Vesce
CBCody D. Blazek
Cody D. Blazek
Background: The Infectious Diseases Society of America guidelines recommend a prolonged course of antibiotics in the setting of residual osteomyelitis. More recently published literature suggests that oral antibiotics may offer comparable outcomes to intravenously administered antibiotics when treating orthopaedic infections. In a prior study, we investigated the outcomes of both routes of antibiotic administration in patients with diabetic foot infections at a single academic medical institution. Methods: The goal of this study is to retrospectively evaluate the therapeutic success in 196 patients receiving oral or intravenous antibiotics for treatment of residual infection following amputation at 2 academic medical centers. Treatment was considered successful if patients who completed a minimum of 4 weeks of antibiotic therapy had complete wound healing and did not require additional debridement or amputation within 1 year of their initial surgery. Results: After performing a retrospective chart review, no difference was determined in treatment success between patients who underwent oral or intravenous antibiotics at either WFBMC ( P = .34) or UPMC ( P = .99). No difference in success was found when combining institutional data ( P = .52). The median time to healing for oral antibiotics was 3.21 months compared with 3.85 months for intravenous ( P = .16). Reoperation rates did not differ among treatment types ( P = .53). Hemoglobin A 1c values were lower among patients with treatment success (8.6 ± 2.3) versus failure (9.5 ± 2.5) ( P = .016). Conclusion: This study supports the consideration of oral antibiotics as a viable option for selected diabetic patients with residual osteomyelitis. No significant differences were observed in treatment success, healing time, or reoperation rates, although the study was not powered to determine equivalence.